Dr. Mohit K Jolly, IISc Bangalore
He is an Associate Professor in the Department of Bioengineering at IISc Bangalore, where he leads the Cancer Systems Biology Research Group. He earned his Ph.D. in Bioengineering from Rice University, focusing on the presence and clinical significance of hybrid epithelial/mesenchymal (E/M) phenotypes in cancer metastasis. He later completed a Gulf Coast Consortia Postdoctoral Fellowship at Rice University and UT MD Anderson Cancer Center.
Dr. Jolly’s pioneering contributions have transformed the understanding of the Epithelial–Mesenchymal Transition (EMT). His theoretical and computational framework — supported by extensive experimental and clinical evidence — demonstrates that EMT is not a binary process but includes stable hybrid E/M states that drive metastasis, therapeutic resistance, and cancer progression. He also directs the Param Hansa Centre for Computational Oncology (PHCCO), an initiative aimed at nurturing India’s next generation of computational oncology researchers through strong interdisciplinary partnerships across academia, medicine, and industry. His sustained efforts to promote cross-domain collaboration — including the PHCCO Computational Oncology Summer Internship at IISc — have been a key inspiration in shaping the vision of this event.
Dr. Pragyan Acharya,
AIIMS New Delhi
She is an Additional Professor in the Department of Biochemistry and leads the Laboratory of Liver Disease Signaling and Immunology (LLDSI) at AIIMS New Delhi. Trained at the National Institutes of Health (NIAID), USA, she directs a cutting-edge research program that integrates high-resolution proteomics, targeted and untargeted metabolomics, and advanced immunology to decipher the molecular circuitry of complex liver diseases.
Her group has been at the forefront of discovering lipidomic and proteomic biomarkers, mapping immune-metabolic pathways in ACLF and MASLD, and developing next-generation diagnostic frameworks-including multi-analyte signatures, mechanistic immune profiling, and POC-ready translational platforms. As a member of the Proteomics Society of India (PSI), the Indian Immunology Society (IIS), and the Indian National Association for the Study of the Liver (INASL), she is committed to bridging fundamental molecular insights with clinically actionable solutions. Beyond her research, she is passionate about mentoring the next generation of clinician-scientists, innovators, fostering rigorous scientific thinking, and building capacity in systems biology and translational medicine across the country.